
Beneficial genetic changes observed in regular blood donors
Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells.

Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells.

Miach Orthopaedics announced today that the FDA cleared an expanded indication for the company’s Bear implant for ACL tears.

Lungpacer Medical announced today that it received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system.

The findings provide new drug targets for stopping the infection’s spread.

Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and regenerative biology since James Thomson isolated the first human embryonic stem cell in 1998.

BREA, Calif., March 10, 2025 /PRNewswire/ — Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration. The DxC 500i combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare. With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, this analyzer delivers precise and reliable results critical for timely clinical decision-making.

Exactech this week announced the first surgical procedures using its Vantage Ankle 3D and 3D+ tibial implants with GPS Ankle navigation.

Think Surgical today announced the first successful use of Waldemar Link’s LinkSymphoKnee using the TMINI Miniature Robotic System.

Erectile dysfunction affects over 40% of men over 40, yet our understanding of the condition remains limited. Research on this issue has mostly relied on real organs, making it difficult to study the detailed interaction between blood flow and tissue during an erection.

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.